Search
News Archive
Categories
Growing revenues for marine ingredient company Aqua Bio Technology
Aqua Bio Technology ASA (Oslo Axess: ABT) recently announced its first quarter 2013 financial results. The Company continued its revenue build-up and posted an EBITDA of 3.9 million.
ABT’s revenues were NOK 7.2 million in the first quarter, against NOK 3.4 million in the previous quarter. In the first quarter of 2012 the Company had revenues of NOK 11.9 million, which included sign-on fees for major contracts.
The sales growth is reflected in the NOK 3.9 million EBITDA, which is up from an EBITDA of NOK 0.2 million the previous quarter. The first quarter of 2012 provided EBITDA of NOK 9.6 million.
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT’s ingredients Aquabeautine XL, Dermaclarine and Beauty Propelline are marine solutions derived from the hatching fluid of salmon, while Oceanx Oil in Serum is based on extract from seaweed.
Release of Mar. Drugs, Volume 11, Issue 5 (May 2013), Pages 1427-1762
MDPI announces the publication of the following issue:
Mar. Drugs, Volume 11, Issue 5 (May 2013), Pages 1427-1762
http://www.mdpi.com/1660-3397/
German Scientists Develop “Omega-3 Sausage”
German scientists have developed a new kind of sausage: One that is enriched with omega-3 fatty acids, which was made possible by a specifically developed and patented technology. The invention, which is now already available in supermarkets and even comes in nine variations, of course including Bratwurst, is a reaction to the problem that Germans do not eat enough fish. And that despite being aware of the fact that omega-3, contained in fatty salt-water fish, is an important component of a healthy diet in humans.
Can Plastic Be Made From Algae?
Scientists working for the SPLASH research project, funded by the EU, are now addressing the challenge of making high-quality, affordable plastics from algae. They need to demonstrate that this new type of bioplastic —namely used to produce polyesters and polyolefins— can be of the same quality as traditional plastic. And they need to show whether it can be produced in an economically viable way.
First Natural Product from Marine Myxobacteria
Although terrestrial myxobacteria have been extensively studied and are known to produce a range of secondary metabolites with a remarkable variety of unusual structures, their marine counterparts have only recently been discovered.
Gabriele M. König and co-workers, University of Bonn, Germany, have isolated a marine myxobacterium from a mud sample from the coast of the island Prerow, Germany. Analysis showed that the bacterium was Enhygromyxa salina, which is closely related to microorganisms previously termed “unculturable”. As this bacterium was found to have persistent antibiotic activity towards gram-positive microorganisms, it was chosen for detailed investigation.
Science devises ways to recycle crustacean shells
It was only a matter of time before scientists found a way to recycle the 750 000 tonnes of crustacean shells which are disposed of in the EU every year.
Asia has successfully managed to extract polymer chitosan (used to make filters, foils and wound dressings) produced from shrimp shells. But in Europe crustaceans contain more lime, so processing is more complex and not economical. Also, the high content of calcium carbonate (known as CaCO3) of EU crab shell waste has prevented cost effective conversions to chitosan so far.
However, a solution has come from the ChiBio Project, which is developing an integrated biorefinery for processing chitin rich biowaste, to specialty and fine chemicals. ChiBio is led by the Straubing Project Group BioCat of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, with a consortium of 11 European partners and has been awarded EU funding of nearly EUR 3 million.
Funding to Boost Algae Company
Algaeon Inc., an Indianapolis-based biotech company that has developed algae cultivation technology for use in the nutraceutical and micronutrient markets, announced today that it has closed a $770,000 investment round of funding from early-stage growth company investors. The investment group included City Securities Corporation and multiple individual Angel investors.
The funding will support the addition of capacity for sample qualification and animal testing for 3 prospective customers and the design of a commercial scale facility. This sets the ground work for the Company to expand operations and to produce products used as food supplements to promote health and disease prevention for humans and animals.
New partnership formed for algae biodiesel aim
LCTI Low Carbon Technologies International, which focuses on clean-tech, environmental and energy efficiency sectors has signed a joint venture with US-based Sunthenoil.
The two want to develop a 1,000 acre algae-to-oil project located on a LCTI site using a technology sub-licensed through Sunthenoil from SunEco Energy of California.
Neste Oil signs algae oil off-take deal with Cellana
Finland-based Neste Oil, the world’s largest producer of renewable diesel, has signed a contingent commercial off-take agreement with Cellana, an algae biomass developer based in San Diego, with production facilities in Hawaii. The agreement will enable Neste Oil to purchase Cellana’s algae oil for use as a feedstock in the future for producing renewable fuel. The agreement is contingent on Cellana’s future production capacity and on compliance with future biofuel legislation in the EU and US, among other factors.
Nofima Scientists Develop Biodegradable Food Packaging Made of Chitin & Chitosan from Shrimp Shell
Scientists at Nofima are participating in a major EU-financed project in which “active” packaging based on raw materials from shrimp shell improves and conserves food products – and after use the packaging biodegrades. Environmentally stubborn plastic is getting competition from biodegradable packaging made of chitin and chitosan from shrimp shell.
Nofima’s part of the project equates to around NOK 1 million over a two-year period. Together with the coordinator, Italian company Mavi, the majority of the project involves four medium-sized companies in EU and three research centres.
“Our job is to ensure food contact safety in the project and quantify the effect on bacteria. Chitosan used as an integrated part of the packaging can have an antibacterial effect on the food products,” says Morten Sivertsvik, Director of Research at Nofima’s department for Processing Technology in Stavanger.
“The EU has strict regulations in this area, and our role is to see that the active packaging have a positive and not negative impact on the food products. The chitosan-based fibres that are used in the packaging are based on nanotechnology, so we are talking about minute particles that by no means have to break down so they come in the food products.”
Sivertsvik has worked on packaging technology at Nofima, Europe’s largest food research institute, since 1992.
Host
 |
Partners
  |
Sponsors
 |
Share Aquapreneur
